Phase transformations of erythromycin A dihydrate during pelletisation and drying.

An at-line process analytical approach was applied to better understand process-induced transformations of erythromycin dihydrate during pellet manufacture (extrusion-spheronisation and drying process). The pellets contained 50% (w/w) erythromycin dihydrate and 50% (w/w) microcrystalline cellulose, with purified water used as a granulating fluid. To characterise changes in solid-state properties during processing, near infrared (NIR) spectroscopy and X-ray powder diffraction (XRPD) were applied. Samples were taken after every processing step (blending, granulation, extrusion, and spheronisation) and at predetermined intervals during drying at 30 or 60 degrees C. During pelletisation and drying at 30 degrees C no changes occurred. Partial transformation to the dehydrated form was observed for the pellets dried at 60 degrees C by NIR and XRPD. The variable temperature XRPD measurements of the wet pellets (from 25 to 200 degrees C) also confirmed the change to erythromycin dehydrate at approximately 60 degrees C.

[1]  Jean Paul Remon,et al.  Extrusion-spheronisation A literature review , 1995 .

[2]  Thermal, phase transition and spectral studies in erythromycin pseudopolymorphs: dihydrate and acetone solvate , 2006 .

[3]  G. Stephenson,et al.  Formation of isomorphic desolvates: creating a molecular vacuum. , 1998, Journal of pharmaceutical sciences.

[4]  G. Stephenson,et al.  Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity. , 1997, Journal of pharmaceutical sciences.

[5]  J. Rantanen,et al.  Pellet manufacturing by extrusion-spheronization using process analytical technology , 2005, AAPS PharmSciTech.

[6]  W. Mccrone,et al.  Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.

[7]  F. Podczeck,et al.  A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  Kinam Park,et al.  Advances in pharmaceutical materials and processing , 1998 .

[9]  J. Rantanen,et al.  Insight into Thermally Induced Phase Transformations of Erythromycin A Dihydrate , 2006 .

[10]  J. Rantanen,et al.  Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction. , 2005, Journal of pharmaceutical and biomedical analysis.

[11]  J. Bauer,et al.  Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. , 1999, Journal of pharmaceutical sciences.

[12]  K R Morris,et al.  Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. , 2001, Advanced drug delivery reviews.

[13]  I. Miroshnyk,et al.  Influence of solvents on the variety of crystalline forms of erythromycin , 2003, AAPS PharmSci.

[14]  Application of NIR spectroscopy in polymorphic analysis: study of pseudo-polymorphs stability. , 2005, Journal of pharmaceutical sciences.

[15]  J. Rantanen,et al.  Understanding processing-induced phase transformations in erythromycin-PEG 6000 solid dispersions. , 2006, Journal of pharmaceutical sciences.

[16]  L. Hasznos,et al.  Some factors influencing pellet characteristics made by an Extrusion/Spheronisation process Part I.: Effects on size characteristics and moisture content decrease of pellets , 1992 .